International Journal of Antimicrobial Agents

Papers
(The H4-Index of International Journal of Antimicrobial Agents is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Title Page & Editorial Board84
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page68
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems66
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms59
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen57
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page56
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis52
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr51
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho50
Title Page & Editorial Board50
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings49
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page45
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page44
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India44
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital43
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat38
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria37
Vaccines against SARS-COV-237
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae37
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon36
Hospitalization decision model for COVID-19 patients with comorbidities35
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page34
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China34
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page34
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis33
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria33
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis32
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans32
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota31
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure31
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo30
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis30
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy30
0.073040962219238